753 related articles for article (PubMed ID: 25443339)
1. Management of acute and chronic HCV infection in persons with HIV coinfection.
Sulkowski MS
J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic HCV genotype 1 coinfection.
Boesecke C; Rockstroh JK
Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population.
Sikavi C; Chen PH; Lee AD; Saab EG; Choi G; Saab S
Hepatology; 2018 Mar; 67(3):847-857. PubMed ID: 29108121
[TBL] [Abstract][Full Text] [Related]
4. Optimizing treatment in HIV/HCV coinfection.
Puoti M; Rossotti R; Travi G; Panzeri C; Morreale M; Chiari E; Cocca G; Orso M; Moioli MC
Dig Liver Dis; 2013 Sep; 45 Suppl 5():S355-62. PubMed ID: 24091116
[TBL] [Abstract][Full Text] [Related]
5. Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.
Meissner EG
Curr Opin Gastroenterol; 2017 May; 33(3):120-127. PubMed ID: 28234770
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-human immunodeficiency virus coinfection.
Sulkowski MS
Liver Int; 2012 Feb; 32 Suppl 1():129-34. PubMed ID: 22212583
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions of hepatitis C direct-acting antivirals in the HIV-infected person.
El-Sherif O; Back D
Curr HIV/AIDS Rep; 2015 Sep; 12(3):336-43. PubMed ID: 26159742
[TBL] [Abstract][Full Text] [Related]
8. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
Wyles DL; Sulkowski MS; Dieterich D
Clin Infect Dis; 2016 Jul; 63 Suppl 1(Suppl 1):S3-S11. PubMed ID: 27363438
[TBL] [Abstract][Full Text] [Related]
9. Advances in the treatment of HIV/HCV coinfection in adults.
Schlabe S; Rockstroh JK
Expert Opin Pharmacother; 2018 Jan; 19(1):49-64. PubMed ID: 29252031
[TBL] [Abstract][Full Text] [Related]
10. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms.
Cooper CL; Klein MB
HIV Med; 2014 Nov; 15(10):621-4. PubMed ID: 24802099
[TBL] [Abstract][Full Text] [Related]
11. Interferon-containing and interferon-free HCV therapy for HIV-infected patients.
Sulkowski MS
Semin Liver Dis; 2014 Feb; 34(1):72-8. PubMed ID: 24782260
[TBL] [Abstract][Full Text] [Related]
12. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
[TBL] [Abstract][Full Text] [Related]
13. The clinical management of HCV in the HIV-infected patient.
Norton B; Naggie S
Antivir Ther; 2015; 20(5):457-67. PubMed ID: 25346056
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
15. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals.
Rockstroh JK
Liver Int; 2015 Jan; 35 Suppl 1():51-5. PubMed ID: 25529087
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.
Sterling RK; Sulkowski MS
Semin Liver Dis; 2004; 24 Suppl 2():61-8. PubMed ID: 15346248
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
Verucchi G; Calza L; Manfredi R; Chiodo F
Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
[TBL] [Abstract][Full Text] [Related]
18. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
Neukam K; Morano-Amado LE; Rivero-Juárez A; Mancebo M; Granados R; Téllez F; Collado A; Ríos MJ; de Los Santos-Gil I; Reus-Bañuls S; Vera-Méndez F; Geijo-Martínez P; Montero-Alonso M; Suárez-Santamaría M; Pineda JA
HIV Clin Trials; 2017 May; 18(3):126-134. PubMed ID: 28599618
[TBL] [Abstract][Full Text] [Related]
19. Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Bruno G; Saracino A
Curr HIV Res; 2017; 15(6):422-433. PubMed ID: 29119934
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on HCV: Current Therapeutic Regimens and Drug-Drug Interactions.
Chan J; Chung RT
Clin Pharmacol Drug Dev; 2017 Mar; 6(2):147-163. PubMed ID: 28263458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
